Wasatch Advisors’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,783
| Closed | -$1.56M | – | 251 |
|
|
2023
Q4 | $1.56M | Sell |
1,783
-1,642
| -48% | -$1.44M | 0.01% | 232 |
|
|
2023
Q3 | $3.21M | Sell |
3,425
-656
| -16% | -$615K | 0.02% | 221 |
|
|
2023
Q2 | $3.93M | Sell |
4,081
-26
| -0.6% | -$25K | 0.02% | 219 |
|
|
2023
Q1 | $4.59M | Buy |
4,107
+1,396
| +51% | +$1.56M | 0.03% | 211 |
|
|
2022
Q4 | $1.78M | Buy |
2,711
+353
| +15% | +$231K | 0.01% | 239 |
|
|
2022
Q3 | $1.99M | Sell |
2,358
-19
| -0.8% | -$16K | 0.01% | 228 |
|
|
2022
Q2 | $2.06M | Buy |
2,377
+746
| +46% | +$646K | 0.01% | 232 |
|
|
2022
Q1 | $2.48M | Buy |
+1,631
| New | +$2.48M | 0.01% | 242 |
|